RecruitingNot ApplicableNCT06290427

Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K)

Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney

Sponsor

Azienda Ospedaliera Universitaria Integrata Verona

Enrollment

30 participants

Start Date

Feb 1, 2024

Study Type

INTERVENTIONAL

Conditions

Renal Carcinoma

Summary

The Urology Unit of AOUI Verona proposes a clinical study aimed at a preliminary evaluation of postoperative complications specifically focused on robotic partial nephrectomy (RAPN) procedures using two currently available platforms: * DaVinci®; * Hugo®. The questions it aims to answer are: Does the estimation of the post-operative complications suggest something? Are differences (intra- and post-operative, oncological, functional, technical, and economic) among the three intervention approaches observable? Participants will be invited to join one of these two experimental group: 1. surgery with the DaVinci platform; 2. surgery with the Hugo platform.

Eligibility

Min Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing outcomes of different robotic surgery platforms used to perform kidney-sparing surgery (partial removal of the kidney) for localized kidney tumors. The goal is to see how different robotic systems compare in safety and effectiveness. **You may be eligible if...** - You are between 18 and 90 years old - You have a localized kidney tumor that can be treated with partial kidney removal - You are able to understand and sign an informed consent form - You are willing to attend follow-up visits **You may NOT be eligible if...** - Your tumor is not suitable for partial kidney removal - You are unable to comply with follow-up requirements - You decline to participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.